The role of dermocosmetics in the management of rosacea: an up-to-date
Keywords:
Rosacea, Pathogenesis, Skincare, Dermocosmetics, Treatment, ManagementAbstract
Dermocosmetic interventions represent an effective support to pharmacology therapy of rosacea, in preventing disease flare-ups, enhancing skin barrier function, and helping reduce inflammation during acute phases.
The aim of this article is to report on the current scientific consensus on the role of dermocosmetics in the management of this disease.
A thorough PubMed literature review on the use of dermocosmetics in this disease highlighted two key aspects: the lack of patient awareness regarding the natural history of their condition and the significant gap in patient and physician education concerning the role of dermocosmetics and skincare as strategies in the management of rosacea.
Effective skincare is mandatory both in the prodromal and the flare-up phases of the disease. Daily care is structured in morning and evening procedures aiming to improve barrier dysfunction, to restore skin hydration, to normalize skin pH, to improve the symptoms of rosacea and patient’s social interaction. The suggested protocols are based on the use of appropriate cleansers, moisturizers, antioxidant serum, adequate photoprotection and camouflage.
References
1. Geng RSQ, Bourkas AN, Mufti A, Sibbald RG. Rosacea: pathogenesis and therapeutic correlates. J Cutan Med Surg. 2024; 28(2):178-189.
2. Del Rosso JQ, Tanghetti E, Webster G, Stein Gold L, Thiboutot D, Gallo RL. Update on the management of rosacea from the American Acne & Rosacea Society (AARS). J Clin Aesthet Dermatol. 2019; 12(6):17-24.
3. Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020; 182(5):1269-1276.
4. Tan J, Steinhoff M, Bewley A, Gieler U. Beyond the visible: Rosacea and psoriasis of the face 2020 https://www.galderma.com/news/galderma-global-research-reveals-struggles-people-rosacea-and-psoriasis-face-experiencing-lack, accessed 2 June 2025.
5. van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: new concepts in classification and treatment. Am J Clin Dermatol. 2021; 22(4):457-465.
6. Nguyen C, Kuceki G, Birdsall M, Sahni DR, Sahni VN, Hull CM. Rosacea: practical guidance and challenges for clinical management. Clin Cosmet Investig Dermatol. 2024; 17:175-190.
7. Juliandri J, Wang X, Liu Z, Zhang J, Xu Y, Yuan C. Global rosacea treatment guidelines and expert consensus points: the differences. J Cosmet Dermatol. 2019; 18:960–965.
8. de Melo Magalhaes Goncalves MMB, Soares Rodriguez Tavares de Pina ME. Dermocosmetic care for rosacea. Braz J Pharm Sci. 2017; 53(4):e00182.
9. Kresken J, Kindl U, Wigger-Alberti W, Clanner-Engelshofen BM, Reinholz M. Dermocosmetics for use in rosacea: guideline of the Society for Dermopharmacy. Skin Pharmacol Physiol. 2018; 31(3):147-154.
10. Sobkowska D, Szałapska A, Pawlaczyk M, et al. The role of cosmetology in an effective treatment of rosacea: a narrative review. Clin Cosmet Investig Dermatol. 2023; 16:1419-1430.
11. Maggioni D, Cimicata A, Praticò A, et al. A preliminary clinical evaluation of a topical product for reducing slight rosacea imperfections. Clin Cosmet Investig Dermatol. 2020; 13:299-308.
12. Del Rosso J, Baldwin H, Bhatia N, et al. A review of the diagnostic and therapeutic gaps in rosacea management: Consensus Opinion. Dermatol Ther (Heidelb). 2024; 14(2):271-284.
13. Jansen T. Clinical presentations and classification of rosacea. Ann Dermatol Venereol. 2011; 138 Suppl 3:S192-200.
14. Fisher GW, Travers JB, Rohan CA. Rosacea pathogenesis and therapeutics: current treatments and a look at future targets. Front Med (Lausanne). 2023; 10:1292722.
15. Berardesca E, Cartigliani C, Nioré M, et al. Randomised, split-face study of a dermocosmetic cream containing Sphingobioma xenophaga extract and Neurosensine® in subjects with rosacea associated with erythema and sensitive skin. Skin Res Technol. 2024; 30(6):e13735.
16. Guder H, Guder S. Investigation of skincare habits and possible rosacea triggers of patients with rosacea: a prospective case-control study. North Clin Istanb. 2024; 11(1):27-37.
17. Baldwin H, Alexis A, Andriessen A, et al. Supplement Article: Skin barrier deficiency in rosacea: an algorithm integrating OTC skincare products into treatment regimens. J Drugs Dermatol. 2022; 21(9):SF3595563-SF35955610.
18. Goh CL, Wu Y, Welsh B, et al. Expert consensus on holistic skin care routine: Focus on acne, rosacea, atopic dermatitis, and sensitive skin syndrome. J Cosmet Dermatol. 2023; 22(1):45-54. Erratum in: J Cosmet Dermatol. 2023; 22(6):1933.
19. Goh CL, Wu Y, Welsh B, et al. Challenges and real-world solutions for adoption of holistic skincare routine (cleansing, treatment, moisturization, and photoprotection) in acne, rosacea, atopic dermatitis, and sensitive skin: an expert consensus. J Cosmet Dermatol. 2024; 23(8):2516-2523.
20. Berardesca E, Bonfigli A, Cribier B, et al. A split-face study assessing the clinical benefit, tolerability and subject satisfaction of a dermocosmetic in subjects with rosacea associated with erythema and sensitive skin. Clin Cosmet Investig Dermatol. 2020; 13:751-758.
21. Vermeer BJ, Gilchrest BA. Cosmeceuticals. A proposal for rational definition, evaluation, and regulation. Arch Dermatol. 1996; 132(3):337-340.
22. Nowicka D, Chilicka K, Dzieńdziora-Urbińska I, Szyguła R. Skincare in rosacea from the cosmetologist's perspective: a narrative review. J Clin Med. 2022; 12(1):115.
23. Pandey A, Jatana GK, Sonthalia S. Cosmeceuticals. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
24. Paiva-Santos AC, Gonçalves T, Peixoto D, et al. Rosacea topical treatment and care: from traditional to new drug delivery systems. Mol Pharm. 2023; 20(8):3804-3828.
25. Desai SR, Baldwin H, Del Rosso JQ, et al. Microencapsulated benzoyl peroxide for rosacea in context: a review of the current treatment landscape. Drugs. 2024; 84(3):275-284.
26. Mijaljica D, Spada F, Harrison IP. Skin cleansing without or with compromise: soaps and syndets. Molecules. 2022; 27(6):2010.
27. Draelos ZD. The science behind skin care: cleansers. J Cosmet Dermatol. 2018; 17(1):8-14.
28. Matz H, Orion E, Wolf R. Balneotherapy in dermatology. Dermatol Ther. 2003; 16(2):132-140.
29. Seite S, Benech F, Berdah S, et al. Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay thermal spring water as monotherapy or adjunctive therapy. J Drugs Dermatol. 2013; 12(8):920-924.
30. Protano C, Vitali M, De Giorgi A, Marotta D, Crucianelli S, Fontana M. Balneotherapy using thermal mineral water baths and dermatological diseases: a systematic review. Int J Biometeorol. 2024; 68(6):1005-1013.
31. Berardesca E, Bonfigli A, Cartigliani C, Kerob D, Tan J. A randomized, controlled clinical trial of a dermocosmetic containing Vichy volcanic mineralizing water and probiotic fractions in subjects with rosacea associated with erythema and sensitive skin and wearing protective masks. Clin Cosmet Investig Dermatol. 2023; 16:71-77.
32. Goldman MP, Merial-Kieny C, Nocera T, Mery S. Comparative benefit of two thermal spring waters after photodynamic therapy procedure. J Cosmet Dermatol. 2007; 6(1):31–35.
33. Merial-Kieny C, Castex-Rizzi N, Selas B, Mery S, Guerrero D. Avène thermal spring water: an active component with specific properties. Acad Dermatol Venereol. 2011; 25(Suppl1):2–5.
34. Nicoletti G, Saler M, Pellegatta T, et al. Ex vivo regenerative effects of a spring water. Biomed Rep. 2017; 7(6):508–514.
35. Saler M, Ferraro O, Faga A, Sansotta D, Villani S, Nicoletti G. Enhancement of human native skin fibroblast proliferation in natural salso-bromo-iodic mineral water added to in vitro culture. Adv Clin Exp Med. 2025; 34(6):925-933.
36. Fabbrocini G, Monteil CB, Carballido F. A cream containing the sap of oat plantlets and mandarin extract soothes the symptoms of rosacea and improves the quality of life of patients. J Eur Acad Dermatol Venereol. 2022; 36 Suppl 8:3-11.
37. Adler BL, Deleo VA. Sunscreen safety: a review of recent studies on humans and the environment. Curr Derm Rep. 2020; 9:1-9.
38. Dobos KA. Shielding our future: the need for innovation in sunscreen active ingredients and safety testing in the United States. J Pediatr Pharmacol Ther. 2025; 30(2):286-288.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Giovanni Nicoletti, Francesca Villa, Magda Belmontesi, Silvia Scevola
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
